XLS
Xlife Sciences
Stock
Stock
ISIN: CH0461929603
Ticker: XLS
CH0461929603
XLS
Price
Price
CHART BY
Frequently asked questions
What is Xlife Sciences's market capitalization?
The market capitalization of Xlife Sciences is $160.57M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Xlife Sciences's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Xlife Sciences is 6.59. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Xlife Sciences?
Xlife Sciences's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.245. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Xlife Sciences's stock?
Currently, 1 analysts cover Xlife Sciences's stock, with a consensus target price of $76.06. Analyst ratings provide insights into the stock's expected performance.
What is Xlife Sciences's revenue over the trailing twelve months?
Over the trailing twelve months, Xlife Sciences reported a revenue of $1.11M.
What is the EBITDA for Xlife Sciences?
Xlife Sciences's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$2.98M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Xlife Sciences?
Xlife Sciences has a free cash flow of $2.12M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Xlife Sciences's shares?
The free float of Xlife Sciences is 2.89M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $160.57M
- EPS (TTM)
- $4.245
- Free Float
- 2.89M
- P/E ratio (TTM)
- 6.59
- Revenue (TTM)
- $1.11M
- EBITDA (TTM)
- -$2.98M
- Free Cashflow (TTM)
- $2.12M
Pricing
- 52W span
- $25.68$60.45
Analyst Ratings
The price target is $76.06 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company was founded in 2019 and is headquartered in Zurich, Switzerland.
- Industries
- Miscellaneous Commercial Services
- Sector
- Financials
Identifier
- ISIN
- CH0461929603
- Primary Ticker
- XLS